AstraZeneca Investor Day Presentation Deck slide image

AstraZeneca Investor Day Presentation Deck

3 Imfinzi+ tremelimumab HIMALAYA Dr Bruno Sangro Principal Investigator, HIMALAYA Phase III trial B
View entire presentation